Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 186(5): 3258-64, 2011 Mar 01.
Article in English | MEDLINE | ID: mdl-21278338

ABSTRACT

Chikungunya virus (CHIKV) is an alphavirus responsible for numerous epidemics in Africa and Asia. Infection by CHIKV is often characterized by long-lasting, incapacitating arthritis, and some fatal cases have been described among elderly and newborns. Currently, there is no available vaccine or specific treatment against CHIKV. Blood B cells from a donor with history of CHIKV infection were activated, immortalized, amplified, and cloned. Two human mAbs against CHIKV, 5F10 and 8B10, were identified, sequenced, and expressed in recombinant form for characterization. In a plaque reduction neutralization test, 5F10 and 8B10 show mean IC(50) of 72 and 46 ng/ml, respectively. Moreover, both mAbs lead to a strong decrease in extracellular spreading of infectious viral particles from infected to uninfected cells. Importantly, the mAbs neutralize different CHIKV isolates from Singapore, Africa, and Indonesia, as well as O'nyong-nyong virus, but do not recognize other alphaviruses tested. Both mAbs are specific for the CHIKV envelope: 5F10 binds to the E2 glycoprotein ectodomain and 8B10 to E1 and/or E2. In conclusion, these two unique human mAbs strongly, broadly, and specifically neutralize CHIKV infection in vitro and might become possible therapeutic tools against CHIKV infection, especially in individuals at risk for severe disease. Importantly, these mAbs will also represent precious tools for future studies on host-pathogen interactions and the rational design of vaccines against CHIKV.


Subject(s)
Alphavirus Infections/immunology , Alphavirus Infections/virology , Antibodies, Monoclonal/physiology , Antibodies, Neutralizing/physiology , Chikungunya virus/immunology , Neutralization Tests/methods , Viral Envelope Proteins/immunology , Alphavirus Infections/prevention & control , Animals , Antibodies, Monoclonal/metabolism , Antibodies, Neutralizing/metabolism , Binding Sites, Antibody , Cell Line, Transformed , Chikungunya virus/pathogenicity , Chlorocebus aethiops , HEK293 Cells , Humans , Immunization, Passive/methods , Immunoglobulin G/metabolism , Recombinant Proteins/metabolism , Vero Cells
2.
J Virol ; 80(1): 85-94, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16352533

ABSTRACT

Betanodaviruses are small positive-sense bipartite RNA viruses that infect a wide variety of fish species and are notorious for causing lethal outbreaks in juvenile fish hatcheries worldwide. The function of a small nonstructural protein, B2, encoded by the subgenomic RNA3 of betanodaviruses, has remained obscure. Greasy grouper nervous necrosis virus, a betanodavirus model, was used to develop a facile DNA-based reverse genetics system that recapitulated the virus infection cycle, and we used this system to show that B2 is a small nonstructural protein that is essential for high level accumulation of viral RNA1 after RNA transfection of fish, mammalian, and avian cells. The defect in RNA1 accumulation in a B2 mutant was partially complemented by supplying B2 RNA in trans. Confocal analysis of the cellular distribution of B2 indicated that B2 is able to enter the nucleus and accumulates there during the late stages of GGNNV infection. Using human HeLa cells as a cellular RNA interference model, we found that B2 could efficiently antagonize RNA interference, which is a property shared by the distantly related alphanodavirus B2 proteins. This function provides appears to provide an explanation, at least in part, for why B2 mutant RNA1 is severely impaired in its intracellular accumulation.


Subject(s)
Nodaviridae/metabolism , RNA Interference , RNA, Viral/metabolism , Viral Nonstructural Proteins/antagonists & inhibitors , HeLa Cells , Humans , Nodaviridae/genetics , Nodaviridae/pathogenicity , Nodaviridae/physiology , Up-Regulation , Viral Nonstructural Proteins/genetics , Viral Nonstructural Proteins/metabolism , Virus Replication
SELECTION OF CITATIONS
SEARCH DETAIL
...